Quantcast

Latest Chronic obstructive pulmonary disease Stories

2014-02-27 23:35:55

A diverse group of experts come together with a shared goal of improving the treatment and management of patients that are diagnosed with Chronic obstructive pulmonary disease (COPD). SAN DIEGO, CA (PRWEB) February 27, 2014 Pulmonary Horizons programs are comprehensive and patient centered; developed by Vernon R Pertelle, MBA, RRT and Robert McCoy, BS, RRT, FAARC to help meet the complex needs of managing patients with COPD. The goals of the Pulmonary Horizons (PH) programs are to...

2014-02-26 20:21:29

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/lvrdps/portable_oxygen) has announced the addition of a new report "Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018" [http://www.researchandmarkets.com/research/lvrdps/portable_oxygen ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Worldwide markets are poised to achieve continuing...

2014-02-25 08:32:43

ALBANY, New York, February 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pulmonary Drug Delivery Systems Market(Products- Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications- Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global pulmonary drug delivery systems market was valued at USD 21.03billion in 2012 and is expected to grow...

2014-02-24 08:29:06

DUBLIN, Feb. 24, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dh9kt6/anesthesia_and ) has announced the addition of the "Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Sophistication and persistent technological advances by respiratory and anesthesia device manufacturers have boosted the growth of this industry....

2014-02-18 23:30:33

This unique program will bring together key stakeholders who have a shared goal of improving the treatment and management of patient’s with Chronic Obstructive Pulmonary Disease (COPD). San Diego, CA (PRWEB) February 18, 2014 The Pulmonary Horizons (PH) Conference will be held at the DoubleTree Golf Resort in San Diego, Saturday, August 16, 2014 to Sunday, August 17, 2014. This unique program will bring together key stakeholders who have a shared goal of improving the treatment and...

2014-02-18 23:22:31

"You Are Not Your COPD" offers encouragement and support to those living with COPD San Francisco, CA (PRWEB) February 18, 2014 Healthline announced the launch of an inspirational stories project today, “You Are Not Your COPD,” in conjunction with the COPD Foundation to provide support and encouragement to those living with COPD. The project encourages individuals living with COPD to upload a photo of themselves together with a message letting the world know they are not...

2014-02-12 23:26:12

2nd Annual Conference of Chronic Obstructive Pulmonary Disease (COPD 2014) will be held for the second time this year in Hilton Convention & Exhibition Center, Istanbul between the 7th and 10th March. (PRWEB) February 12, 2014 COPD 2014 will be held for the second time this year in Hilton Convention & Exhibition Center, Istanbul between the 7th and 10th March. As Chronic Obstructive Pulmonary Disease is becoming more and more prevalent in our lives, the latest researches and the...

2014-02-11 08:33:38

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States. LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients...

2014-02-11 08:30:39

KONTICH, Belgium, February 11, 2014 /PRNewswire/ -- The Flemish agency for Innovation by Science and Technology (IWT) has awarded a consortium led by the Belgian-based company FLUIDDA a grant of 1MEUR to conduct research to increase survival rates after lung transplantation through Functional Respiratory Imaging (FRI). The international consortium includes, besides FLUIDDA and its long-term research partner Materialise (Leuven, Belgium), also the University of Antwerp...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.